Daxor Co. (NASDAQ:DXR – Get Free Report) saw a large increase in short interest in the month of September. As of September 30th, there was short interest totalling 15,900 shares, an increase of 7.4% from the September 15th total of 14,800 shares. Based on an average daily trading volume, of 5,500 shares, the days-to-cover ratio is currently 2.9 days. Currently, 0.8% of the company’s shares are short sold.
Daxor Price Performance
Daxor stock remained flat at $9.00 during mid-day trading on Wednesday. 284 shares of the company were exchanged, compared to its average volume of 3,931. The firm’s 50-day moving average price is $8.91 and its 200 day moving average price is $9.11. Daxor has a 52 week low of $7.11 and a 52 week high of $10.04.
Analyst Upgrades and Downgrades
Separately, Ascendiant Capital Markets raised their target price on shares of Daxor from $24.50 to $24.75 and gave the company a “buy” rating in a report on Monday, September 9th.
Daxor Company Profile
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions.
Featured Articles
- Five stocks we like better than Daxor
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- CD Calculator: Certificate of Deposit Calculator
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- How to Use Stock Screeners to Find Stocks
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Daxor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daxor and related companies with MarketBeat.com's FREE daily email newsletter.
